This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dion's Monday ETF Winners and Losers


iShares Silver Trust (SLV): +1.6%

Precious metals continue to lead the commodities, with silver outshining gold in today's market opening. ETFS Physical Palladium Shares (PALL), another precious metals fund, is also carrying its weight, which speaks well for investor faith in industrials (since the metal is heavily used in the sector).

iShares MSCI Sweden Index (EWD): + 2.2%

European products suffered across the board last week, so a rebound from the Swedish fund is a welcome breath of air for international investors. Market Vectors Brazil Small Cap ETF (BRF) and Market Vectors Vietnam ETF (VNM) are also outperforming among international ETFs today.

Claymore/MAC Global Solar Index (TAN): + 1.3%

Although suffering a shaky year, TAN opened reasonably well this week, recovering some of the losses incurred over last week's decline. Thanks to a sizeable (roughly 30%) representation in China, a nation leading the world in energy consumption, some analysts have an optimistic outlook for the fund. Granted, alt-energy funds have endured a rough year thus far, so be cautious.


United States Natural Gas Fund, LP (UNG): -2.6%

The fund is only about 5% away from a 52-week low, and some analysts claim that this bottoming out may signify an upcoming bounce. Granted, if natural gas prices continue on their downward path (as they have done throughout the year, particularly since mid June), the fund's suffering may continue.

Biotech HOLDRs (BBH): -1.1%

The fund has endured its fair share of ups and downs throughout 2010, growing until mid to late March. Although BBH appeared to be on its way back up as of early August, it and the biotech sector took a turn for the worst in August and has been suffering ever since.

Pharmaceutical HOLDRs (PPH): -0.1%

Pharmaceuticals are off to a bad start this week, just as the Food and Drug Administration released alarming statistics on prescription drug recalls. The organization recently reported 1,742 separate drug recalls took place during 2009, monumentally higher than the 426 attributed to prior year. Meanwhile, 2010 recall numbers thus far look to be well over the norm -- drug recalls totaled 296 from January through June of this year.

All prices as of 2:15 PM EST
At the time of publication, Dion Money Management had no positions in stocks mentioned.

Don Dion is president and founder of Dion Money Management, a fee-based investment advisory firm to affluent individuals, families and nonprofit organizations, where he is responsible for setting investment policy, creating custom portfolios and overseeing the performance of client accounts. Founded in 1996 and based in Williamstown, Mass., Dion Money Management manages assets for clients in 49 states and 11 countries. Dion is a licensed attorney in Massachusetts and Maine and has more than 25 years' experience working in the financial markets, having founded and run two publicly traded companies before establishing Dion Money Management.

Dion also is publisher of the Fidelity Independent Adviser family of newsletters, which provides to a broad range of investors his commentary on the financial markets, with a specific emphasis on mutual funds and exchange-traded funds. With more than 100,000 subscribers in the U.S. and 29 other countries, Fidelity Independent Adviser publishes six monthly newsletters and three weekly newsletters. Its flagship publication, Fidelity Independent Adviser, has been published monthly for 11 years and reaches 40,000 subscribers.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
PPH $69.05 0.10%
BBH $129.85 -0.38%
UNG $12.55 -2.40%
SLV $13.80 -0.86%
EWD $30.11 -1.20%


Chart of I:DJI
DOW 16,478.25 -164.76 -0.99%
S&P 500 1,976.96 -11.91 -0.60%
NASDAQ 4,808.28 -20.0450 -0.42%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs